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By Jessica Greene, Judith H. Hibbard, Rebecca Sacks, Valerie Overton, and Carmen D. Parrotta
When Patient Activation Levels
Change, Health Outcomes And
Costs Change, Too
ABSTRACT Patient engagement has become a major focus of health
reform. However, there is limited evidence showing that increases in
patient engagement are associated with improved health outcomes or
lower costs. We examined the extent to which a single assessment of
engagement, the Patient Activation Measure, was associated with health
outcomes and costs over time, and whether changes in assessed activation
were related to expected changes in outcomes and costs. We used data on
adult primary care patients from a single large health care system where
the Patient Activation Measure is routinely used. We found that results
indicating higher activation in 2010 were associated with nine out of
thirteen better health outcomes—including better clinical indicators,
more healthy behaviors, and greater use of women’s preventive screening
tests—as well as with lower costs two years later. Changes in activation
level were associated with changes in over half of the health outcomes
examined, as well as costs, in the expected directions. These findings
suggest that efforts to increase patient activation may help achieve key
goals of health reform and that further research is warranted to examine
whether the observed associations are causal.
P
atient engagement has become a
central pillar of health policy. The
Affordable Care Act emphasizes pa-
tient engagement and activation,
with initiatives that focus on shared
decision making, wellness, and self-manage-
ment.1,2 Health care delivery systems, payers,
foundations, and community organizations are
making major investments in patient engage-
ment programs.3–5
There is evidence that links better outcomes
with more engaged and activated patients.6–13
However, there is limited evidence that increases
in patient activation track with improvements in
outcomes and lower costs.14–17 If current patient
engagement initiatives are successful and more
patients become better managers of their health
and health care, will those changes yield im-
proved health outcomes and reductions in cost?
In this analysis we begin to explore this ques-
tion by examining the association between pa-
tient activation and outcomes over time and
whether increases in activation levels are related
to improved health outcomes and lower costs. If
such associations were found, it would not imply
that changes in patient activation caused the
changes in outcomes. However, it would be con-
sistent with that possibility and would indicate
that further research is warranted to examine
whether the association is causal.
Background
The Patient Activation Measure is the metric
most often used to quantify a patient’s “engage-
ment,” activation, or self-management capabili-
ties. Designed to assess a person’s knowledge,
skill, and confidence related to managing his or
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her health and health care, the measure is a
thirteen-item scale that has proved to have
strong psychometric properties.1
The construct of activation is not condition
specific, and the measure is not focused on a
specific behavior. Thus, activation is broader
than earlier concepts such as locus of control,
self-efficacy, and readiness to change, which typ-
ically focus on changing one specific behavior.
Activation is associated with a wider range of
outcomes than these previous concepts.2,6
There is a growingbodyof literature indicating
that those patients who are more activated, as
assessed by the Patient Activation Measure,
makemore effective use of health care resources
and engage in more positive health behaviors
compared to other patients.7 For example, pa-
tients with results on the measure that indicate
higher activation are more likely to have a regu-
lar source of care, more likely to obtain preven-
tive care, and less likely to delay getting care,
compared to less activated patients.8 This is true
after differences in sociodemographic factors
and insurance status are controlled for. The Pa-
tient Activation Measure scoring system is dis-
cussed in detail below.
In addition, less activated patients are almost
twice as likely as more activated patients to be
readmitted to the hospital within thirty days of a
discharge.9 More activated patients are more
likely to ask questions in themedical encounter,
seek out health information, and know about
treatment guidelines for their condition.10,11
Studies of the relationship between thePatient
Activation Measure and health outcomes have
been conducted in a variety of settings, with dif-
ferent population groups, andwith patients who
have different conditions. The majority of these
studies are cross-sectional. However, there are
some studies that follow patients over time and
assess how well the Patient Activation Measure
predicts future health outcomes and health be-
haviors.12,13 Finally, a growing number of inter-
ventional studies indicate that patient activation
is changeable and that specific interventions de-
signed to increase activation are able to do so.14–21
An earlier large cross-sectional investigation
of Patient ActivationMeasure scores and health-
related outcomes derived from electronic health
records found that the scores were significant
predictors of clinical indicators such blood pres-
sure, use of preventive screening services, un-
healthy behaviors such as smoking and obesity,
anduse of costly care such as in-hospital or emer-
gency department (ED) care.22 In a related study,
patients at the lowest PatientActivationMeasure
level had predicted health care costs that were
8 percent higher than the costs of those at the
highest level, after health care risk and demo-
graphic characteristics were controlled for.23
In the current study we expanded on this ear-
lier work to assess whether a patient’s Patient
Activation Measure score is associated with fu-
ture outcomes and to examine what happens to
quality and cost outcomes when a person’s score
changes. This is the largest longitudinal investi-
gation to date to assess the relationship between
patient activation levels and future health out-
comes and cost. Furthermore, it is the first ob-
servational study to assess whether changes in
Patient Activation Measure scores are related to
changes in outcomes and the costs of care. The
score changes took place within a delivery sys-
tem where the patients received usual care. That
is, therewas no specific intervention designed to
increase patient activation.
Study Data And Methods
We conducted a longitudinal study of primary
care patients at Fairview Health Services, a large
not-for-profit health care system with forty-four
primary care clinics in Minnesota. Since 2010
Fairview has routinely collected Patient Activa-
tion Measure scores during primary care office
visits. In 2010, 18 percent of adult patients com-
pleted the assessment; in2011, 54percent did so.
In 2012, when Fairview implemented a policy to
collect the scores only for new patients, those
with a new diagnosis, and those with chronic
conditions who were not meeting quality met-
rics, the rate dipped to 34 percent.
SampleWeexamined twogroups of adult Fair-
view patients. The first group had a baseline Pa-
tient Activation Measure score collected in 2010
and follow-up outcomes collected in 2012
(n ¼ 32;060). The second group had two scores
taken in two consecutive years, between 2010
and 2012 (n ¼ 10;957). Sample sizes for specific
analyses were often smaller, as indicated in the
exhibits, because the dependent variables were
applicable for subsets of patients.
Independent Variable Patient activation,
which was assessed using the Patient Activation
Measure, refers to having the knowledge, skill,
and confidence to manage one’s health and
health care. The Patient ActivationMeasure con-
sists of thirteen statements about managing
one’s health, such as “I am confident that I can
tell a doctor my concerns, even when he or she
does not ask.” Respondents use a four-point
Likert-type scale of agreement or disagreement
to respond to each item. The items form an in-
terval level, unidimensional, Guttman-like scale
with strong psychometric properties.1,24
Themeasure is scored on a scale from0 to 100.
Four levels of activation have been identified,
which reflect a developmental progression from
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beingpassivewith regard toone’shealth tobeing
proactive.24 These patient activation levels are
the independent variable in this study.
Level 1 (indicated by a score of 0.0–47.0) sug-
gests that a person may not yet understand that
the patient’s role is important. Level 2 (47.1–
55.1) indicates that a person lacks the confidence
and knowledge to take action. Level 3 (55.2–
72.4) indicates that a person is beginning to
engage in recommended health behaviors. And
level 4 (72.5–100) indicates that a person is pro-
active about health and engages in many recom-
mended health behaviors.
Dependent Variables We examined thirteen
health-related outcomes across four areas: clini-
cal indicators, healthy behaviors, preventive
screening, and avoidance of costly utilization.
The clinical indicators examined were hemoglo-
bin A1c, high-density lipoprotein (HDL), low-
density lipoprotein (LDL), serum triglycerides,
systolic blood pressure, diastolic blood pressure,
and a measure of depression severity commonly
known as the PHQ-9 (Patient Health Question-
naire-9). Healthy behaviors were not being a
current smoker and not being obese (that is,
having a body mass index of less than 30). For
preventive screening,weused two cancer screen-
ing measures for women: the Pap smear and
mammography. For avoidance of costly utiliza-
tion, we examined having no ED visits and not
having been hospitalized in the calendar year of
observation. All of the outcome variables were
dichotomous. For the clinical indicators, we de-
termined whether values were in the “normal”
range according to widely used cutoff points.25–28
Our measure of cost of care was total annual
medical charges from Fairview, which included
inpatient andoutpatient care, ED, andpharmacy
costs. Medical charges do not include the nego-
tiated discounts that health insurance compa-
niespay formedical services.However, theyhave
the benefit of being consistent across insurance
providers and are often used a proxy for medical
costs.23,29,30
Analyses To examine the relationships be-
tween activation level in 2010 and outcomes in
2012, we used multivariate regression models
(bivariate versions of all analyses are available
upon request from the authors). The models
controlled for differences in patient age, sex,
mean income for ZIP code (transformed by nat-
ural logarithm), and number of the following
chronic conditions: asthma, diabetes, hyperten-
sion, congestive heart failure, coronary artery
disease, hyperlipidemia, and chronic obstructive
pulmonarydisease. Forutilization (EDvisits and
hospitalizations) and costs, we also controlled
for the percentage of total medical charges that
werebilledby theFairviewsystem(hospital costs
and total costs, respectively, since our medical
charge data were only from Fairview). Data from
one large insurer were used to compute the per-
centage of totalmedical charges at the clinic level
that were from Fairview. All models were adjust-
ed for clustering of patients by primary care
provider.
For the health-related outcomes, we developed
logistic regression models, since all of the out-
comes were dichotomous. For costs, we used an
ordinary least squares linear regression model
with a log transformed dependent cost variable.
We then developed predicted costs at each level
of activation. To interpret predicted costs, we
transformed costs back from log dollars to dol-
lars using the Duan smear factor.31
To examine whether changes in Patient Acti-
vation Measure level over one year were associ-
ated with changes in outcomes, we first deter-
mined whether people remained at a given level
or moved to a higher or lower level. Specifically,
we categorized people into one of seven groups.
From highest to lowest activation, these groups
consisted of people who were at level 4 in both
time periods, at 3 and then at 4, at 3 in both time
periods, at 4 and then at 3, at 1 or 2 and then at 3
or 4, at 3 or 4 and then at 1 or 2, and at 1 or 2 in
both time periods. We combined some levels
(typically levels 1 and 2) because of small
numbers.
We then developed multivariate regression
models with the independent variable being
the categorization of the patient’s Patient Acti-
vation Measure change in the seven groups de-
scribed above. The dependent variables were the
health and cost outcomes at follow-up. Themod-
els controlled for the patient’s dependent vari-
able value at baseline (for example, whether or
not the patient was in the normal range at base-
line) and for the factors in the previous models.
Again, the models were adjusted for clustering
by primary care provider.
Limitations This study’s findings are limited
by several factors. The studywas conductedwith-
in one large delivery system in Minnesota, so its
findings might not be generalizable to other
more diverse settings. Furthermore, as the on-
line Appendix shows,32 the patients who com-
pleted the Patient Activation Measure at Fair-
view were not entirely representative of all
Fairview patients: They were somewhat older,
had higher chronic illness burden, and resided
in lower-income ZIP codes. In addition, patients
who had two Patient Activation Measure scores
collected had even higher rates of chronic con-
ditions, in part because of how the scores were
collected starting in 2012.
It is also important to note that the Patient
Activation Measure scores and clinical indica-
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tors were obtained during the same calendar
year (for example, baseline or follow-up year).
However, we did not have an exact date within
the year for either the score or the clinical indi-
cator. Thus, althoughbothmight have beenmea-
sured in 2010, we did not know which came first
or exactly when they were measured.
Our data were also limited in that we hadmed-
ical charge data from Fairview, not the actual
amounts paid to providers. Additionally, we con-
trolled for patients’ health status using the num-
ber of seven key chronic conditions a patient
had. Unfortunately, we did not have amore com-
prehensive severity measure. Finally, it is possi-
ble that the associations we observed reflected
the influence of another unmeasured factor that
was related to both the Patient Activation Mea-
sure level and the outcomes.
Study Results
The study samples were disproportionately fe-
male (60–64 percent; for descriptive statistics
on the samples, see the Appendix).32 Approxi-
mately half of the patients in each sample were
age fifty-one or older. On average, patients had
approximately one chronic disease. Patient acti-
vation levels were very comparable across the
samples, with approximately four out of five pa-
tients in the top two levels of activation. This
positive skew is consistent with national data
on patient activation.5
In multivariate regression analysis, higher
baseline activation levels were predictive of bet-
ter outcomes two years later for nine health in-
dicators (Exhibit 1). Specifically, a higher level in
2010 was related to greater odds of having HDL,
triglycerides, and PHQ-9 in the normal range;
not smoking or being obese; having had the pre-
ventive cancer screening tests for women (Pap
smear and mammography); and not having
costly utilization (ED visit or hospitalization) in
2012.
The relationships suggested a dose-response
association. In other words, the greater the acti-
vation level, the greater the odds of a positive
outcome. The odds ratios were almost always
lowest for level 1, generally slightly higher for
level 2, and higher (and sometimes not signifi-
cantly different from the level 4 reference group)
for level 3. For example, compared to the refer-
ence group (level 4), the odds ratios for having
HDL in the normal range were 0.66 for level 1,
0.69 for level 2, and 0.84 for level 3 (Exhibit 1).
The predicted average per capita costs in 2012
were the same ($6,719) for patients at levels 3
and 4 in 2010 (Exhibit 2). The costs were 12 per-
cent higher for patients at level 2 and 8 percent
higher for those at level 1.
Among people with two Patient Activation
Measure scores, there was considerable change
in the level from one year to the next (data not
shown). Fifty-eight percent stayed at the same
level in the two consecutive years. Of the 42 per-
cent who did not, 12 percent moved from level 4
to level 3, while 9 percent moved in the reverse
direction. Therewas a similar pattern formoving
in and out of lower levels, with 12 percent mov-
ing fromlevels 1or2 to levels3or4, and9percent
moving in the other direction.
Exhibit 3 shows the results of the multivariate
analyses that examined changes in Patient Acti-
vation Measure levels over one year and follow-
uphealth outcomes, after baseline outcomes and
other factors were controlled for. People who
were at the lowest levels in both periods had
significantly lower odds (0.74–0.31) of having
positive outcomes for seven of the thirteen
health outcomes (HDL, serum triglycerides,
PHQ-9, not smoking, not being obese, having
no ED visits, and having no hospitalizations),
compared to those who remained at level 4 in
both periods. People who dropped to low levels
(1 or 2) fromhigh levels (3 or 4) had significantly
lower odds of positive health outcomes for five of
the thirteen measures, compared to those who
Exhibit 1
Relationship Between Patient Activation Measure Levels And Health Outcomes Two Years
Later, Odds Ratios
2010 Patient Activation Measure levela
Outcomes in 2012 (number of patients) 1 2 3
Clinical indicators in normal range
Hemoglobin A1c (5,547) 0.92 0.79** 0.85**
High-density lipoprotein (14,106) 0.66**** 0.69**** 0.84****
Low-density lipoprotein (14,531) 0.97 0.97 0.96
Serum triglycerides (14,058) 0.76**** 0.77**** 0.88***
Systolic blood pressure (25,224) 1.03 0.91** 0.93**
Diastolic blood pressure (25,224) 0.94 0.96 0.96
PHQ-9 (7,294) 0.45**** 0.60**** 0.80***
Healthy behaviors
Not a current smoker (25,522) 0.64**** 0.65**** 0.81****
Not obese (25,358) 0.62**** 0.62**** 0.79****
Preventive screenings
Pap smear (14,848) 0.65**** 0.83*** 0.96
Mammography (8,180) 0.63**** 0.81** 0.89
Avoidance of costly utilization
No ED visits (32,060) 0.72**** 0.79**** 0.95
No hospitalizations (32,060) 0.79*** 0.86** 0.98
SOURCE Authors’ analysis of data from Fairview Health Services. NOTES The exhibit shows odds
ratios. For example, a person with a Patient Activation Measure level of 3 (the levels are
described in the text) has significantly lower odds of not being obese than a person with a level
of 4. Level 4 is most activated and is the reference group (odds ratio ¼ 1:00). Factors that were
controlled for were age, sex, number of chronic conditions, the natural logarithm of income,
and—for costly utilization measures—the clinic-level percentage of hospital costs that were
from within Fairview. Results were adjusted for clustering by provider. PHQ-9 (Patient Health
Questionnaire-9) is a measure of depression severity. aLevel 4 activation is the reference group.
**p < 0:05 ***p < 0:01 ****p < 0:001
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remained at level 4. There were also three signif-
icant differences between thosewho remained at
level 4 and those who dropped from 4 to 3.
A similar pattern appears in the results for
change in Patient Activation Measure level and
billed costs (Exhibit 4). The lowest average per
capita cost ($6,411) was predicted for patients
who were at level 4 in both periods. Costs were
significantly higher for all but the next-most-
activated group (those who went from level 3
to level 4). For instance, people whomoved from
4 to 3 had projected costs that were 14 percent
higher than those who remained at 4. Those who
moved from 3 or 4 to 1 or 2 had projected costs
that were 27 percent higher than those of the
lowest-cost group, and those who remained in
1 or 2 had costs that were 31 percent higher than
those of the lowest-cost group.
Discussion
The findings show that baseline Patient Activa-
tionMeasure levels are related to clinical, behav-
ioral, andutilizationoutcomes twoyears later, as
well to future health care costs. After age, sex,
number of chronic conditions, and income were
controlled for, more activated patients were sig-
nificantlymore likely than less activated patients
to have HDL, serum triglycerides, and PHQ-9 in
the normal range; to be nonsmokers; and not to
be obese. More activated patients were also sig-
nificantlymore likely than less activated patients
to have obtained cancer screening tests (Pap
smears and mammography), and they were
significantly more likely to not have a hospitali-
zation or ED visit two years after the Patient
Exhibit 2
Predicted Average Per Capita Costs In 2012, By Patient Activation Measure Level In 2010
SOURCE Authors’ analysis of data from Fairview Health Services. NOTES Patient Activation Measure
level 1 is least activated (measure levels are described in the text). Factors that were controlled
for were the indicator at baseline and patient age, sex, number of chronic conditions, the natural
logarithm of income, and the percentage of clinic-level costs that were from within Fairview. Results
were adjusted for clustering by provider.
Exhibit 3
Relationship Between Patient Activation Levels At Two Time Periods And Follow-Up Health Outcomes, Odds Ratios
Patient Activation Measure levels in two time periodsa
Outcome in follow-up year
(number of patients)
Incr. from
3 to 4
Remained
at 3
Decr. from
4 to 3
Incr. from 1 or
2 to 3 or 4
Decr. from 3 or
4 to 1 or 2
Remained at
1 or 2
Clinical indicators in normal range
Hemoglobin A1c (1,778) 1.36 1.53** 0.89 0.88 0.80 0.84
High-density lipoprotein (5,386) 0.81 0.81** 0.93 0.73** 0.72*** 0.70**
Low-density lipoprotein (4,425) 1.09 1.16 1.09 1.12 1.49*** 0.96
Serum triglycerides (1,789) 0.76 0.78 0.84 0.66** 0.69 0.60**
Systolic blood pressure (10,897) 0.93 0.93 1.07 0.96 0.88 1.08
Diastolic blood pressure (10,897) 1.00 0.91 1.02 0.95 0.91 0.95
PHQ-9 (2,030) 0.66** 0.74 0.61** 0.48**** 0.27**** 0.31****
Healthy behaviors
Not a current smoker (10,769) 0.99 0.92 0.98 0.90 0.71 0.74**
Not obese (10,804) 0.88 0.72*** 0.75** 0.63*** 0.69** 0.53****
Preventive screenings
Pap smear (5,300) 0.90 1.13 0.92 0.85 1.07 0.69
Mammography (2,956) 1.04 0.96 0.83 1.05 1.19 0.88
Avoidance of costly utilization
No ED visits (10,927) 0.87 0.87 0.73*** 0.70**** 0.73*** 0.65****
No hospitalizations (10,927) 0.98 0.82 0.78 0.79 0.72** 0.72**
SOURCE Authors’ analysis of data from Fairview Health Services. NOTES The exhibit shows odds ratios. For example, a person with a Patient Activation Measure level of 1
or 2 (the lowest levels of activation, further described in the text) in two consecutive years in the period 2010–12 has the smallest chance of having high-density
lipoprotein in the normal range. People who were at level 4 in both time periods are the reference group (odds ratio ¼ 1:00). Factors that were controlled for were
the indicator at baseline and patient age, sex, number of chronic conditions, the natural logarithm of income, and—for costly utilization measures—the clinic-level
percentage of hospital costs that were from within Fairview. Results were adjusted for clustering by provider. PHQ-9 (Patient Health Questionnaire-9) is a measure
of depression severity. a“Remained at level 4” is the reference group. **p < 0:05 ***p < 0:01 ****p < 0:001
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Activation Measure level was collected. Further-
more, patients at higher levels (3 or 4) had pro-
jected costs that were 8 percent lower than those
at level 1 and 13 percent lower than those at level
2 (Exhibit 2).
The findings also show that when Patient Ac-
tivationMeasure levels change, health outcomes
tend to change in the same direction, and costs
follow as predicted. Of note, costs were signifi-
cantly higher for those who dropped a level over
one year and significantly lower for those who
increased a level, compared to those who stayed
at the same level. For instance, people who
dropped from level 4 to level 3 had predicted
costs that were 14 percent higher than those
who stayed in level 4. Conversely, those who
went from 3 to 4 had projected costs that were
9 percent lower than those who remained at 3.
We found that the association between activa-
tion and outcomes is lasting and that when the
Patient Activation Measure level moves, out-
comes move in the expected direction. Future
research is needed to establish whether or not
the association represents a causal relationship.
If it does, improving activation could have im-
portant implications.
For instance, if the 3,021 people who dropped
from level 4 to level 3 had stayed in level 4, the
annual charges would have been $2.6 million
less, given the difference in predicted costs for
the two groups. These projections are based up-
on the sample of patients with two Patient Acti-
vation Measure scores at Fairview, who—as not-
ed above—were not representative of all patients
in Fairview, or of US patients more broadly. Fu-
ture work should examine more generalizable
samples.
Conclusion
This is the largest observational study to examine
the relationshipbetweenPatientActivationMea-
sure levels andoutcomes over time, and to assess
whether outcomes change when these levels do.
We found that levels were related to many out-
comes over time and that changes in levels were
related to changes in the expected direction in
several of the outcomes studied, including cost.
Accountable care organizations and other de-
livery systems are seeking to restrain costs and
improve outcomes. The findings reported here
do not prove causality. However, they do suggest
that delivery systems might wish to investigate
the value of supporting patient activation as a
potential pathway to these goals. Future research
is needed to assess whether delivery system ini-
tiatives aimed at increasing patient activation
provide a return on their investments. ▪
This research was funded by the Gordon
and Betty Moore Foundation. Judith
Hibbard is an equity stakeholder in and
a consultant to Insignia Health.
Exhibit 4
Predicted Average Per Capita Costs In Follow-Up Year, By Change In Patient Activation Measure Levels During Two Time
Periods
SOURCE Authors’ analysis of data from Fairview Health Services. NOTES Patient Activation Measure level 1 is least activated (measure
levels are described in the text). Levels were collected in two consecutive years in the period 2010–12. Factors that were controlled
for were the indicator at baseline and patient age, sex, number of chronic conditions, the natural logarithm of income, and the per-
centage of clinic-level costs that were from within Fairview. Results were adjusted for clustering by provider.
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